PIM-1 kinase inhibitors (Baltimore VA Medical)

N/A

Report date: 2025/03/20 09:57:18
NME

Base Information

Drug NamePIM-1 kinase inhibitors (Baltimore VA Medical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene serine/threonine-protein kinase Pim-1 inhibitors
TargetsProto-oncogene serine/threonine-protein kinase Pim-1
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaltimore Va Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesBaltimore Va Medical Center
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A